Silvercrest Asset Management Group LLC Amphastar Pharmaceuticals, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $13.6 Billion
- Q1 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 165,856 shares of AMPH stock, worth $4.19 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
165,856
Previous 166,814
0.57%
Holding current value
$4.19 Million
Previous $6.19 Million
22.36%
% of portfolio
0.04%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...